The term white-coat hypertension (WCH) refers to a condition characterized by an elevation of blood pressure (BP) in the office with normal ambulatory or home values. Previous studies have estimated a prevalence of this condition ranging from 15-20% to 40-50% of individuals with elevated office BP. A controversy currently exists on whether WCH is a benign phenomenon and how it should be best defined. Some studies suggest that patients with the condition have a risk of cardiovascular events similar to patients with normotension, whereas others document an increased rate of target organ damage and cardiovascular events. 1 In some patients, WCH may deteriorate to persistent hypertension in the future, leading to the risk of cardiovascular events as a long-term outcome. Individuals with high-normal BP, additional cardiovascular risk factors (eg, obesity, metabolic syndrome, advanced age, and impaired glucose tolerance), and organ damage may be particularly susceptible to a poor prognosis in the presence of WCH. According to two recent meta-analyses, WCH is associated with a slightly increased risk of cardiovascular events compared with normotension, although this risk is well below that seen in either persistent hypertension or masked hypertension. Briasoulis et al 2 analyzed 14 studies with 29 100 participants and showed that individuals with WCH had higher rates of cardiovascular disease morbidity and mortality but not significantly different all-cause mortality and stroke risk compared with patients with normotension. Huang et al 3 analyzed 23 cohorts of 20 445 untreated individuals, 11 cohorts of 8656 treated individuals, and a mixed population including both treated and untreated patients (12 cohorts, 21 336 individuals) and concluded that WCH is associated with long-term risk of cardiovascular disease and total mortality in untreated and mixed populations but not in treated patients. All of the studies included in these meta-analyses based categorization of WCH either on ambulatory or home BP. In case of ambulatory BP, the most common definition of WCH was based on daytime BP only, thus excluding nighttime BP. However, many people have normotension during waking hours and hypertension during night sleep, and may thus be mistakenly classified as having WCH. Yet, there are few data comparing the prevalence and consequences of using daytime (awake), full 24hour, rather than nighttime (sleep), periods to define WCH. In fact, heterogeneity among recommendations from the different guidelines exists and there is currently controversy on which period of the day is most suitable for defining WCH (Table 1). The article by Anstey et al, 11 published in the present issue of the Journal of Clinical Hypertension, may help yield further evidence to unravel the dispute. In their study, based on a relatively large sample of black individuals in the community-based prospective cohort Jackson Heart Study, the authors showed that the prevalence of WCH may substantially vary according to the periods of the 24 hours used for classif...